Evidence map›Paper›PMID 40509325›Full record

ArticleMolecules (Basel, Switzerland)2025

Development of 2,1,3-Benzothiadiazole-Based Room-Temperature Fluorescent Nematic Liquid Crystals.

Muhammad Suhail Bin Uzair, Yoshimichi Shimomura, Takuya Tanaka, Takashi Kajitani, Gen-Ichi Konishi

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Muhammad Suhail Bin UzairDepartment of Chemical Science and Engineering, Institute of Science Tokyo, Tokyo 152-8552, Japan.
Yoshimichi ShimomuraDepartment of Chemical Science and Engineering, Institute of Science Tokyo, Tokyo 152-8552, Japan.
Takuya TanakaDepartment of Chemical Science and Engineering, Institute of Science Tokyo, Tokyo 152-8552, Japan.
Takashi KajitaniCore Facility Center, Research Infrastructure Management Center, Institute of Science Tokyo, Yokohama 226-8501, Japan.
Gen-Ichi KonishiDepartment of Chemical Science and Engineering, Institute of Science Tokyo, Tokyo 152-8552, Japan.ORCID 0000-0002-6322-0364

Funding

MEXT/JSPS KAKENHI grants 23H02036
6 · The paper itself

Abstract

Fluorescent liquid crystals (LCs) have attracted considerable interest owing to their unique combination of fluidity, anisotropy, and intrinsic emission. However, most reported fluorescent LCs exhibit high phase transition temperatures and/or smectic phases, limiting their practical applications. To address this, we designed and synthesized a series of 2,1,3-benzothiadiazole (BTD)-based fluorescent nematic liquid crystals incorporating donor (D) or acceptor (A) groups to form D-A-D or D-A-A structures. Most of the synthesized derivatives exhibited supercooled nematic phases at room temperature. They composed various functional groups, such as secondary alkylamine, branched alkyl chain, and trifluoroacetyl groups, which are rarely used in calamitic nematic LCs. Notably, dimethylamine- and carbonyl-substituted derivatives exhibited relatively high fluorescence quantum yields (Φ

Indexed as

2,1,3-benzothiadiazolefluorescent LCnematic liquid crystalroom temperature LC

Identifiers

PMID40509325
PMCPMC12155834

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.